Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Martyn P.T. Kennedy"'
Autor:
Luke T. A. Mounce, Bobby Bhartia, Stephen H Bradley, Matthew E.J. Callister, Nathaniel Luke Fielding Hatton, Martyn P.T. Kennedy, Bethany Shinkins, Richard D Neal, William Hamilton, Pete Wheatstone
Publikováno v:
The British Journal of General Practice
BackgroundChest X-ray (CXR) is the first-line investigation for lung cancer in many healthcare systems. An understanding of the consequences of false-negative CXRs on time to diagnosis, stage, and survival is limited.AimTo determine the sensitivity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680876a13e1b60b2d66f9ef96e82d94f
https://doi.org/10.3399/bjgp.2020.1099
https://doi.org/10.3399/bjgp.2020.1099
Publikováno v:
Journal of the Royal Society of Medicine
After the National Lung Screening Trial (NLST)1 demonstrated improved lung cancer mortality almost a decade ago, hopes have been raised that low-dose computed tomography could be used to detect lung cancer in asymptomatic populations and improve outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6318396783a943e8d374269294cd98c
https://doi.org/10.1177/0141076821991108
https://doi.org/10.1177/0141076821991108
Autor:
Stephen H Bradley, Matthew E.J. Callister, Nathaniel Luke Fielding Hatton, Luke T. A. Mounce, Bobby Bhartia, Martyn P.T. Kennedy, William Hamilton, Bethany Shinkins, Richard D Neal, Rehima Aslam
Publikováno v:
The British Journal of General Practice
BackgroundChest X-ray (CXR) is the first-line investigation for lung cancer in many countries but previous research has suggested that the disease is not detected by CXR in approximately 20% of patients. The risk of lung cancer, with particular sympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd5ed91b3b31ef1588a94c1332e8c56
https://doi.org/10.3399/bjgp20x713993
https://doi.org/10.3399/bjgp20x713993
Publikováno v:
Primary Health Care Research & Development. 23
Objectives: Symptom awareness campaigns have contributed to improved early detection of lung cancer. Previous research suggests that this may have been achieved partly by diagnosing lung cancer in those who were not experiencing symptoms of their can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7b14ce34a8926329b8f1c52f263e503
https://doi.org/10.1017/s1463423622000573
https://doi.org/10.1017/s1463423622000573
Autor:
Philip A.J. Crosbie, Doytchin Dimov, Alison Boland, Matthew E.J. Callister, Deborah Ellames, Martyn P.T. Kennedy, Claire Bradley, Panos Alexandris, Rhian Gabe
Publikováno v:
Lung cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c70221161cfda05578ed827de4d67058
https://doi.org/10.1183/13993003.congress-2021.oa4315
https://doi.org/10.1183/13993003.congress-2021.oa4315
Autor:
Matthew E.J. Callister, Martyn P.T. Kennedy, Michael Darby, Claire Bradley, Rhian Gabe, Philip A.J. Crosbie
Publikováno v:
Imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa3b2fe1955208eec2445727b8d4e35a
https://doi.org/10.1183/13993003.congress-2021.pa1862
https://doi.org/10.1183/13993003.congress-2021.pa1862
Autor:
Samantha L Quaife, Michael Darby, Matthew E.J. Callister, Rhian Gabe, Mike Messenger, Henrik Møller, Nazia Ahmed, Richard D Neal, Mark Sculpher, Kevin Franks, Una Macleod, Irene Simmonds, Suzanne Rogerson, Philip A.J. Crosbie, Richard Booton, Ann Cochrane, Puvanendran Tharmanathan, Sam M. Janes, David J. Torgerson, Martyn P.T. Kennedy, Rachael L Murray, Sebastian Hinde, David R Baldwin
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
BASE-Bielefeld Academic Search Engine
BMJ Open
BASE-Bielefeld Academic Search Engine
BMJ Open
IntroductionLung cancer is the world’s leading cause of cancer death. Low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20% in the US National Lung Screening Trial. Here, we present the Yorkshire Lung Screening Trial (Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207abf277a9648a36f05bc14c8208e31
https://pubmed.ncbi.nlm.nih.gov/32912947
https://pubmed.ncbi.nlm.nih.gov/32912947
Autor:
Andrew Sloss, Corinne Faivre-Finn, Lucy McParland, Peter Allen, Richard Booton, Rachel Naylor, Walter M Gregory, Martyn P.T. Kennedy, Clive Peedell, Sue E. Bell, Kevin Franks, Peter Hall, Fiona Collinson, Catherine Olivier, Jonathan Ferguson, Matthew Evison, Matthew E.J. Callister, David Sebag-Montefiore, Michael Snee, Babu Naidu, Jenny Hewison, Joanne Webster, Janine C Bestall, David R Baldwin
Publikováno v:
N Franks, K, McParland, L, Webster, J, R Baldwin, D, Sebag-Montefiore, D, Evison, M, Booton, R, Faivre-Finn, C, Naidu, B, Ferguson, J, Peedell, C, EJ Callister, M, Kennedy, M, Hewison, J, Bestall, J, M Gregory, W, Hall, P, Collinson, F, Olivier, C, Naylor, R, Bell, S, Allen, P, Sloss, A & Snee, M 2020, ' SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resection ', European Respiratory Journal . https://doi.org/10.1183/13993003.00118-2020
ObjectivesStereotactic ablative radiotherapy (SABR) is a well-established treatment for medically inoperable peripheral stage I nonsmall cell lung cancer (NSCLC). Previous nonrandomised evidence supports SABR as an alternative to surgery, but high-qu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f4f6ec36917486a39b8a1df6bf6480
https://www.pure.ed.ac.uk/ws/files/149781978/SABRTOOTH_ARTICLE_ERJ_Resubmission_FINAL_clean2.pdf
https://www.pure.ed.ac.uk/ws/files/149781978/SABRTOOTH_ARTICLE_ERJ_Resubmission_FINAL_clean2.pdf
Publikováno v:
Advances in Therapy
Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e1a432775200e70dd04d65fcb8fc50
https://doi.org/10.1007/s12325-018-0843-5
https://doi.org/10.1007/s12325-018-0843-5
Autor:
Richard Milton, Martyn P.T. Kennedy, Francesca Hewitt, Victoria Ashford-Turner, K. Rodger, E Paramasivam, Ruth H Jack, Veronica Lovatt, P Malhotra, Alison Gill, Henrik Møller, Paul K. Plant, Bobby Bhartia, Louise Cresswell, Matthew E.J. Callister, J. Robson, L. Cheyne, Victoria H. Coupland, Michael Darby, Margreet Lüchtenborg, Annette Johnstone, Catherine Foster, Shishir Karthik
Publikováno v:
Thorax. 73:1128-1136
BackgroundLung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes.MethodsAn early diagnosis campaign for lung cancer commenced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3022eb4d1a033e35ee3211002447ce6d
https://doi.org/10.1136/thoraxjnl-2018-211842
https://doi.org/10.1136/thoraxjnl-2018-211842